Specific gut microbiota features and metabolic markers in postmenopausal women with obesity

Nutrition and Diabetes

Volumn 5, Issue , 2015, Pages

  Brahe, L K ^a   Le Chatelier, E ^b   Prifti, E ^b   Pons, N ^b   Kennedy, S ^b   Hansen, T ^c   Pedersen, O ^c   Astrup, A ^a   Ehrlich, S D ^b   Larsen, L H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Paris Saclay   (France)

^c Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AKKERMANSIA MUCINIPHILA; ARTICLE; BACTERIAL GENE; BACTEROIDES; BACTEROIDES FAECIS; BIFIDOBACTERIUM LONGUM; BILOPHILA WADSWORTHIA; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; DOREA LONGICATENA; FAECALIBACTERIUM PRAUSNITZII; FAT INTAKE; FECES ANALYSIS; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; LIPID METABOLISM; MACRONUTRIENT; METAGENOMICS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 84931262545     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2015.9     Document Type: Article

References (41)

1. Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834-841.
2. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-945.
3. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489: 220-230.
4. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500: 585-588.
5. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500: 541-546.
6. Brahe L, Le Chatelier E, Prifti E, Pons N, Kennedy S, Blædel T et al. Dietary modulation of the gut microbiota-a randomized controlled trial in obese postmenopausal women. Br J Nutr 2015 (in press).
7. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498: 99-103.
8. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60.
9. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227.
10. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL et al. The long-term stability of the human gut microbiota. Science 2013; 341: 1237439.
11. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh SA et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108.
12. Muegge BD, Kuczynski J, Knights D, Clemente JC, González A, Fontana L et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011; 332: 970-974.
13. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol2007; 73: 1073-1078.
14. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563.
15. Koren O, Goodrich J, Cullender T, Spor A, Laitinen K, Kling Bäckhed H et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012; 150: 470-480.
16. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
17. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484.
18. Karlsson FH, Fak F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012; 3: 1245.
19. Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013; 11: 868-875.
20. Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513: 59-64.
21. Treuth MS, Hunter GR, Kekes-Szabo T. Estimating intraabdominal adipose tissue in women by dual-energy X-ray absorptiometry. Am J Clin Nutr 1995; 62: 527-532.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
23. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
24. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation: Brussels, Belgium, 2006.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36: S67-S74.
26. Duncan SH, Aminov RI, Scott KP, Louis P, Stanton TB, Flint HJ. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Microbiol 2006; 56: 2437-2441.
27. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 2004; 54: 1469-1476.
28. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105: 2420-2428.
29. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls dietinduced obesity. Proc Natl Acad Sci USA 2013; 110: 9066-9071.
30. Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014; 63: 727-735.
31. Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010; 104: 83-92.
32. Karlsson CL, Onnerfalt J, Xu J, Molin G, Ahrne S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 2012; 20: 2257-2261.
33. Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol 2014; 80: 5935-5943.
34. Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 2013; 11: 1075-1083.
35. Kalliomaki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87: 534-538.
36. Schwiertz A, Taras D, Schafer K, Beijer S, Nicolaas AB, Donus C et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18: 190-195.
37. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010; 61: 69-78.
38. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2012; 62: 1112-1121.
39. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of transgalactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 2013; 143: 324-331.
40. Lecerf JM, Depeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L et al. Xylooligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 2012; 108: 1847-1858.
41. Dikeman CL, Fahey GC. Viscosity as related to dietary fiber: a review. Crit Rev Food Sci Nutr 2006; 46: 649-663.